GeoVax Labs Inc.

5.39-0.2200-3.92%Vol 285.26K1Y Perf -30.30%
Jun 18th, 2021 16:00 DELAYED
BID5.31 ASK5.43
Open5.56 Previous Close5.61
Pre-Market- After-Market-
 - -  - -%
Target Price
8.00 
Analyst Rating
— — 0.00
Potential %
48.42 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★★+     59.77
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★★+     64.45
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap34.05M 
Earnings Rating
Price Range Ratio 52W %
8.72 
Earnings Date
9th Aug 2021

Today's Price Range

5.215.58

52W Range

2.5635.00

5 Year PE Ratio Range

-0.70000.0000

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Buy
Performance
1 Week
-0.55%
1 Month
1.89%
3 Months
3.65%
6 Months
63.33%
1 Year
-30.30%
3 Years
-100.00%
5 Years
-100.00%
10 Years
-100.00%

TickerPriceChg.Chg.%
GOVX5.39-0.2200-3.92
AAPL130.46-1.3300-1.01
GOOG2 511.35-16.0700-0.64
MSFT259.43-1.4700-0.56
XOM60.40-1.5900-2.56
WFC41.75-1.0400-2.43
JNJ161.98-3.2400-1.96
FB329.66-6.8500-2.04
GE12.78-0.2200-1.69
JPM147.92-3.8400-2.53
Financial StrengthValueIndustryS&P 500US Markets
46.10
46.40
0.00
0.01
-26.40
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
-
-310.50
-308.60
-245.20
-
RevenueValueIndustryS&P 500US Markets
1.22M
0.19
17.55
24.07
Earnings HistoryEstimateReportedSurprise %
Q01 2021--0.29-
Q03 2020--0.73-
Q02 2020--0.03-
Q01 2020--0.13-
Q03 2019-1 620.00-60.0096.30
Q02 2019-1 960.00-2 020.00-3.06
Q01 2019--2 860.00-
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date9th Aug 2021
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume285.26K
Shares Outstanding6.32M
Trades Count1.07K
Dollar Volume3.21M
Avg. Volume1.39M
Avg. Weekly Volume247.20K
Avg. Monthly Volume293.63K
Avg. Quarterly Volume829.39K

GeoVax Labs Inc. (NASDAQ: GOVX) stock closed at 5.39 per share at the end of the most recent trading day (a -3.92% change compared to the prior day closing price) with a volume of 285.43K shares and market capitalization of 34.05M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 9 people. GeoVax Labs Inc. CEO is David A. Dodd.

The one-year performance of GeoVax Labs Inc. stock is -30.3%, while year-to-date (YTD) performance is 59.47%. GOVX stock has a five-year performance of -100%. Its 52-week range is between 2.56 and 35, which gives GOVX stock a 52-week price range ratio of 8.72%

GeoVax Labs Inc. currently has a PE ratio of -6.00, a price-to-book (PB) ratio of 1.66, a price-to-sale (PS) ratio of 29.45, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -35.68%, a ROC of -40.78% and a ROE of -43.15%. The company’s profit margin is -%, its EBITDA margin is -308.60%, and its revenue ttm is $1.22 Million , which makes it $0.19 revenue per share.

Of the last four earnings reports from GeoVax Labs Inc., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. GeoVax Labs Inc.’s next earnings report date is 09th Aug 2021.

The consensus rating of Wall Street analysts for GeoVax Labs Inc. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for GeoVax Labs Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

GeoVax Labs Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

GeoVax Labs Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 20.30, ATR14 : 0.37, CCI20 : 32.09, Chaikin Money Flow : -0.16, MACD : 0.06, Money Flow Index : 72.13, ROC : 3.06, RSI : 51.71, STOCH (14,3) : 47.57, STOCH RSI : 0.00, UO : 44.52, Williams %R : -52.43), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of GeoVax Labs Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

GeoVax Labs Inc.

Geovax Labs Inc is US-based clinical-stage biotechnology company. It is engaged in developing immunotherapies and vaccines against cancers and infectious diseases using a novel patented Modified Vaccinia Ankara-Virus Like Particle (GV-MVA-VLP) vector vaccine platform. The development programs of the company focused on preventive vaccines against Human Immunodeficiency Virus (HIV), Zika Virus, hemorrhagic fever viruses, and malaria, as well as therapeutic vaccines for chronic Hepatitis B infections and cancers. The product pipeline includes HIV-Clade B Preventive Vaccine, HIV-Clade B Immunotherapy, Hemorrhagic Fever Vaccines, Zika Vaccine, Malaria vaccine, and Cancer Immunotherapy.

CEO: David A. Dodd

Telephone: +1 678 384-7220

Address: 1900 Lake Park Drive, Smyrna 30080, GA, US

Number of employees: 9

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

Bearish Bullish

50%50%

News

Stocktwits